CURRICULUM VITAE

Fanak Fahimi, Pharm D, Clinical Pharmacy Specialist

Academic Degree

Associate Professor of Clinical Pharmacy (Pharmacotherapy)

Personal information

Offices:

1- Clinical Pharmacy Department, School of Pharmacy, Shahid Beheshti University

of Medical Sciences, Niayesh & Vali e Asr intercept, Opposite to Goharbin

Jewelry.

Tel.: +98 21 88873704, 88200081

2- Pharmaceutical Care Department, Masih Daneshvari Hospital, Shahid Beheshti

University of Medical Sciences.

Telefax:+98 21 26109503

E-mail: fanakfahimi@yahoo.com fahimi@sbmu.ac.ir

Date of Birth: Sep. 22, 1971

Education/Degree

2004: Research Fellowship in Diabetes, Tulane Med. Center, New Orleans, LA, USA.

2003: Clinical Pharmacy Residency Training Program, Tehran University of Medical

Sciences,

Faculty of Pharmacy, Iran.

1995: Doctor of Pharmacy, Pharm D. Tehran University of Medical Sciences,

Faculty of Pharmacy, Iran.

Licensure

Pharmcy Licenses

Taking FPGEE exam on Sep. 27, 2011 in USA. Score: 135/150

Iranian Board Certified Pharmacotherapy Specialist (iBCPS)

Clinical Pharmacy Practitioner (Pharm D)

Registered Pharmacist (Iranian Medical Council ID :D-5185)

Other Professional Licenses

Training course on Pharmacovigilance,Uppsala- Sweden,

12-23 May 2003.

Drug & Therapeutic Committees (DTC)& Training of Trainers(TOT) Course,

Kampala, Uganda, Aug. 29- Sep. 11, 2004.

Evidence Based Medicine, SBMU, Iran, 2005

Pharmacy Internship and Observation Sabbatical, Brigham’s and Womens

Hospital/Boston, Ma. Jan. 2013/April 2013.

Professional & Clinical Experiences

Iranian Society of Clinical Pharmacy

Position:

Member from 2008- 2013

Iranian Board of Clinical Pharmacy

Position:

Secretary of Clinical Pharmacy Board,Dec. 2008 to Sep. 2010

Member of Clinical Pharmacy Board, Dec. 2008 to present

Clinical Pharmacy Department, School of Pharmacy, Shahid Beheshti University

Position:

Head of the Department, 2005-2007

Pharmaceutical Care Department, Masih Daneshvari Hospital: National

Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti

Medical University, Tehran, Iran.

Position:

Head of Pharmaceutical Care Department at Masih Daneshvari Hospital,

Aug 2004- present

Services and activities:

Clinical pharmacy section is staffed by:

* Clinical pharmacy specialists and residents (Pharmacotherapists)

* Pharmacists

* Pharmacy students

Consistent with the mission of the department of Clinical Pharmacy (Pharmacotherapy),

located in Pharmacy School, programs focus on activities that contribute directly to

professional and scientific works resulting in advancement of practice, safety, education

and optimizing drug therapy in the hospital.

The activities are listed below:

1. Anticoagulation management services (inpatient and out patient)

2. Drug safety (drug - related morbidity, adverse drug reaction, dose individualization,

interaction, special patient population monitoring, medication errors, ...)

3. Management and strategy (implementing management strategy in hospital pharmacy,

reengineering of services to meet new demands, addressing leadership questions ...)

4. Drug information (drug information on a specific disease, development in information

delivery ...)

5. Clinical Pharmacy (intervention, patient specific pharmacotherapy, outcome

assessment ...)

6. Hospital pharmacy practice (formulary management, DTC, IV admixture)

7. Monthly drug bulletin (mainly devoted to interesting cases detected in the hospital)

8. Clinical pharmacokinetics (Calculation, TDMs, ...)

9. Clinical pharmacy researches (mostly designed to result in optimal pharmaceutical

care)

10. Pharmacy student and clinical pharmacy resident education

11. Basic pharmacological researches aimed at investigating cellular mechanism of drug

handling and toxicity (e.g. polymorphism)

12. Extemporaneous formulation

13. Drug protocols and treatment guidelines : establishment, implementation and

evaluation.

Community Pharmacy Externship Course Coordinator & Instructor

Faculty of Pharmacy,

Shahid Beheshti Medical University,

Tehran, Iran.

June. 2000-2003.

Drug Information Course Coordinator & Instructor

Faculty of Pharmacy,

Shahid Beheshti Medical University,

Tehran, Iran.

Sep. 1999-2002.

Pharmacy Consultant

Tehran Emergency Building, Poison Information Center

Feb. 1999- Feb. 2001.

Vice Pharmacy Consultant

Dubai Iranian Hospital,

Aug. 2000- Sep. 2000.

Medical Rep.(Product Specialist)

Glaxo-Welcome Pharmaceutical Company (Tehran office: Jahan Behbood)

Feb. 1998- Apr. 1998 (Quited to start residency program)

Staff Pharmacist

Polyclinic Pharmacy

Imam Khomeini General Hospital,

May. 1997-May. 1998.

Pharmacy Manager

Pediatrics Amirkabir Hospital,

June. 1995-May. 1997.

Awards

1. Best researcher of the year (Shahid Beheshti University of Medical Sciences)

2007

2. 3rd

rank as “Best Educational Teaching Methods” (countrywide) 2009 Motahari

competition

3. 4th

rank as “Best Educational Teaching Methods” (Shahid Beheshti University of

Medical Sciences) 2010 Motahari competition

4. Best researcher of the year (Shahid Beheshti University of Medical Sciences)

2010

5. 5th

rank in Razi Festival “Health Services Research Section” 2011

Publications:

1. Fahimi F, Siavoshi F, Ala Sh. Effect of pretreatment with ethanol or ammonium

hydroxide on Helicobacter pylori colonization in the stomach of rats.

ActaMedicaIranica.2002; 40(1): 33-7.

2. Ahmadi-Abhari SA, Ghaeli P, Fahimi F, Esfahanian F, Farsam H, Dehpour AR,

Jahanzad I, Hatmi ZN, Dashti S. Risk factors for thyroid abnormalities in bipolar

patients receiving lithium. BMC Psychiatry.2003; 3: 4.

3. Dashti-Khavidaki S, Ahmadi-Abhari SA, Ghaeli P, Farsam H, Dehpour AR,

Mahdavi-Mazdeh M, Hatmi ZN, Fahimi F. Relationship between erythrocyte

lithium concentration and renal concentrating capacity. J Clin Pharm Ther.

2003;28(6):451-6.

4. Ahmadi-Abhari SA, Farhoodian A, Noroozian M, Ghaeli P, Dashti-Khavidaki S,

Sadeghi M, Dehpour AR, Fahimi F. Lithium erythrocyte concentrations and

neurological toxicity in bipolar disorder. Journal of Pharmacy Practice and

Research. 2005; 35(2): 103-5.

5. Richard B, Fahimi F, Naderi N. Improving Risk Factors in Diabetic Patients

Participating in a Weight Management Program. Southern Medical Journal.

2005; 98(4):496-7.

6. Fahimi F. Should Clinical Services Provided by Pharmacists be Compensated?

IJPR.2007; 6(1):1-2.

7. Fahimi F, Moradi M, Safarnavadeh T, Namdar R. Review of the management of

community acquired pneumonia in a teaching hospital: assessment of the role of

established guidelines. Tanaffos. 2007;6(2): 35-40.

8. Fahimi F, Baniasadi S, Malekmohammad M. Neurologic and Psychotic Reaction

Induced by Lidocaine. Journal of Bronchology.2007;14(1):57-8.

9. Baniasadi S, Fahimi F, Mansouri D. Serum Sickness-Like Reaction Associated

with Two Cephalosporins, Cefuroxime and Ceftriaxone. The Annals of

Pharmacotherapy. 2007;41(7):1318-19.

10. Fahimi F,Baniasadi S,Behzadnia N, Varahram F, Ghazi Tabatabaie

L.Enoxaparine utilization evaluation:an observatioinal prospective study in

medical inpatients. Iranian J Pharm Res.2008;7(1): 77-82.

11. Fakharian F, Fahimi F, Salamzadeh J, Mohammadi M, Masjedi MR.Spiromertric

improvements with two commonly used spacers in asthmatic patients.Tanaffos.

2008; 7(3): 37-40.

12. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction

reporting system at a teaching hospital.Basic Clin Pharmacol Toxicol. 2008;

102(4):408-11.

13. Fahimi F, Sistanizad M, Abrishami R, Baniasadi S. An observational study of

errors related to the preparation and administration of medications given by

infusion devices in a teaching hospital. Iranian J Pharm Res.2007;6(4): 295-9.

14. Fahimi F, Ariapanah P, Faizi M, Shafaghi B, Namdar R, Tavakoli Ardakani M.

Errors in preparation and administration of intravenous medications in the

intensive care unit of a teaching hospital: an education program: Resident

observational study. Aust Crit Care. 2008; 21(2):110-16.

15. Fahimi F, Baniasadi S, Amini S. Adverse drug reactions in the post coronary

care unit inpatients of a teaching hospital. Iranian J Pharm Res. 2008;7(3): 223-

8.

16. Fahimi F, Abbasi Nazari M, Abrishami R, Sistanizad M, Mazidi T, Faghihi T,

Soltani R, Baniasadi S. Transcription errors observed in a teaching hospital.Arch

Iran Med. 2009;12(2):173-5.

17. Baniasadi S, Fahimi F, Namdar R. Development of an adverse drug reaction

bulletin in a teaching hospital. Formulary. 2009; 44:333-5.

18. Fahimi F, Baniasadi S, Najafizadeh K. Dose switch to another dosage form of

Neoral increase the risk of medication error?Ann Transplant. 2009;14(4):58-60.

19. Fahimi F, Salamzadeh J, Jamaati HR, Sohrabi S, Fakharian A, Mohammadtaheri

Z. Do statins improve lung function in asthmatic patients? A randomized and

double-blind trial. IJPS.2009; 5(1): 13-20.

20. Sakhaiyan E, Hadjibabaie M, Gholami Kh, Fahimi F, Shamshiri AR,

Alimoghaddam K, Iravani M, Mousavi A, Ardeshir Gh. Drug utilization

evaluation of imipenem in patients undergoing bone marrow transplantation.

IJHOSCR (. 2009;3(2): 10-13.

21. Dezfouli AA, Najafizadeh K, Parsa T, Shadmehr MB, Dabir S, Mohammadi F,

Tabarsi P, Lankarani MM, Assari S, Marjani M, Fahimi F, Shafaghi S, Faeghi J,

Masjedi MR. Postlung transplant rehospitalization: a study of causes, health care

burden, and outcomes. Exp Clin Transplant. 2009;7(3):192-6.

22. Baghaei P, Tabarsi P, Chitsaz E, Saleh M, Marjani M, Shemirani S, Pooramiri

MV, Kazempour M, Farnia P, Fahimi F, Mansouri D, Masjedi M. Incidence,

clinical and epidemiological risk factors, and outcome of drug-induced hepatitis

due to antituberculous agents in new tuberculosis cases. Am J Ther.

2010;17(1):17-22.

23. Baniasadi S, Beizaee S, Kazemi B, Behzadnia N, Shafaghi B, Bandehpour M,

Fahimi F. Novel VKORC1 mutations associated with warfarin sensitivity.

Cardiovasc Ther. 2010;29(4):e1-5.

24. Baniasadi S, Eftekhari P, Tabarsi P, Fahimi F, Raoufy MR, Masjedi MR,

Velayati AA. Protective effect of N-acetylcysteine on antituberculosis drug-

induced hepatotoxicity. Eur J Gastroenterol Hepatol. 2010;22(10):1235-8.

25. Fahimi F. Implementation of a clinical pharmacy education program in a

teaching hospital: Resident oriented documentation and intervention. Iranian J

Pharm Res. 2010; 9 (3): 297-302.

26. Tavallaee, Fahimi F, Kiani S. Drug use patterns in an Intensive Care Unit of a

hospital in Iran: an observational prospective study. International Journal of

Pharmacy Practice. 2010;18(6):370-6.

27. Fahimi F, Kobarfard F, Tabarsi P, Hemmati S, Baniasadi S, Salamzadeh J.

Isoniazid blood levels in patients with pulmonary tuberculosis at a tuberculosis

referral center. Chemotherapy. 2011;57(1):7-11.

28. Fahimi F, Sharif Kashani B, HosseinAhmadi Z, Salamzadeh J, Namdar R,

Mousavi S, Ziaie S, Ghazi Tabatabaei L, Tavallaee M, Radmand G, Baniasadi

S*, Masjedi MR. The first pharmacist-based warfarin monitoring service in Iran.

JPHSR (Journal of Pharmaceutical Health Services Research).2010; 2(1):59-62.

29. Fahimi F, Amini S, Khodadad K, Naghibi F, Salamzadeh J, Baniasadi S.

Evaluation of the effect of zingiber officinalis on nausea and vomiting in patients

receiving cisplatin based regimens. Iranian J Pharm Res. 2011;10(2): 379-84.

30. Fahimi F*, Sahraee Z, Amini S. Evaluation of Stat Orders in a Teaching

Hospital. Clinical Drug Investigation.2011; 31(4):231-5.

31. Haj Hossein Talasaz A, Khalili H, Fahimi F, Salarifar M. Potential role of N-

acetylcysteine in cardiovascular disorders. Therapy. 2011; 8(3): 237-45.

32. Fahimi F, Kobarfard F*, Salamzadeh J, Fakharian A, Abdollahi P, Talasaz A,

Baniasadi S, Masjedi MR. The Bioavailability of Salbutamol in Urine via Volumatic

and Nonvolumatic Valved Holding Chambers. World Allergy Organization Journal.

2011;4(11):179–183.

33. Hashemian M, Cahill N, Murch L, Wang M, Jamaati H, Malekmohammad M,

Farzanegan B, Tabarsi P, Marjani M, Sadr M, Fahimi F, Bagheri A, Ghiasi F,

Asadi P, Hatami B, Chitsazan M, Najafi A, Jamshidi M, Hedayat K, Radmand G,

Bayanzade A, Masjedi M, Heyland D. Improving the Practice of Nutrition

Therapy in the NRITLD Critically III Patients: An International Quality

Improvement Project. Tanaffos. 2011; 10(4): 31-7.

34. Fahimi F, Hashemian S*, Baniasadi S, Ghafari S, Tabarsi P, Najafi A, Akhzarmehr A,

Jamaati HR. Clinical efficacy of bolus versus continuous-infusion of piperacillin-

tazobactam in VAP treatment. Indian Journal of Critical Care. 2012; 16(3): 141–7.

35. Baniasadi S, Fahimi F*. Adverse drug reactions in a pulmonary teaching hospital:

incidence, pattern, seriousness, and preventability. Current Drug Safety.

2011;6(4):230-6.

36. Ziaie S, Jamaati H, Hajimahmoudi M, Hashemian SM, Fahimi F, Farzanegan B,

Moghaddam Gh, Radmand G, Vahdani B, Nadji SA, Mousavi S, Hamishekar H,

Mojtahedzadeh M. The relationship between vitamin E plasma and BAL

concentrations, SOD activity and ventilator support measures in critically III patients.

Iranian J Pharm Res. 2011;10(4):953-60.

37. Haj Hossein Talasaz A, Fahimi F*, Jahangard Rafsanjani Z, Ziaie S. Evaluation

of the pattern of human albumin utilization at a university affiliated hospital.

Arch Iran Med. 2012; 15(2): 85 - 7.

38. Fahimi F*, Emami S, Rashid Farrokhi F. The rate of antibiotic dosage

adjustment in renal dysfunction at a university hospital. Iranian J Pharm

Res.2012;11 (1):157-61.

39. Malek Mohammad M, Fahimi F*, Fakharian A, Karimi M, Sistanizad M, Fayazi N,

Khalilzadeh S*. Methacoline challenge test as an evaluator of response to statins in

bronchial hyperresponsiveness. Iranian J Pharm Res. 2012; 11(3): 969-77.

40. Adimi naghan P, Fahimi F*, Nadji SA, Naderi N, Soleymani F, Masjedi MR. A pilot

study of polymorphism of adrenergic beta-2 receptor and mild asthma: A Clinical and

Pharmacogenetic Study. Iranian J Pharm Res. 2013; 12(1): 199-204.

41. Emami S, Riazi Esfahani H, Rashid Farokhi F, Fahimi F*. Assessment of drug dose

adjustment in patients with kidney disease at a tertiary care hospital: Opportunities for

pharmacist involvement. International Journal of Pharmacy and Pharmaceutical

Sciences. 2012; 13(4): 178-81.

42. Fahimi F. How medical representative influence prescribers behaviour? Iranian J

Pharm Res. 2012;11(2):1.

43. Fahimi F*, Baniasadi S, Mortazavi A, Dehghan H, Zarghi A. Physical and

chemical stability of mycophenolate mofetil (MMF) suspension prepared at the

hospital. Iranian J Pharm Res. 2012; 11(1):171-5.

44. Baniasadi S, Fahimi F*, Kobarfard F. Extemporaneous preparation and stability

assessment of omeprazole suspension in a teaching hospital. IJPTP. 2012; 3(4):

418-21.

45. Foroughinia F, Seifi S, Baniasadi S, Fahimi F*. Vincristine-induced seizure

potentiated by itraconazole following R-CHOP chemotherapy for diffuse large B-cell

lymphoma.Current Drug Safety. 2012; 7(5):372-4.

46. Baniasadi S*, Dorudinia A, Karimi M, Fahimi F. Microbial contamination of

single- and multiple-dose vials after opening in a pulmonary teaching hospital.

The Brazilian journal of infectious diseases: an official publication of the

Brazilian Society of Infectious Diseases. 2013; 17(1): 69-73.

47. Baniasadi S, Habibi M, Haghgoo R, Karimi Gamishan M, Dabaghzadeh F, Farasatinasab M,

Farsaei S, Gharekhani A, Kafi H, Karimzadeh I, Kharazmkia A, Najemeddin F, Nikvarz N,

Oghazian MB, Rezaee H, Sadeghi K, Tafazzoli A, Shahsavari N, and Fahimi F *. Increasing

the number of adverse drug reactions reporting: the role of clinical pharmacy residents.

Iranian J Pharm Res. 2014; 13(1)

48. Allameh Z, Mehrpooya M, Baniasadi S, Fahimi F*. Clinical pharmacy services in an

Iranian teaching hospital: type, severity, resolution, and accuracy. Journal of Research

in Pharmacy Practice. 2013; 2(1): 10-17.

49. Fahimi F, Soleymani F, Tavakoli M*. Vancomycin utilization evaluation in a teaching

hospital: A case- series study in Iran. Journal of Pharmaceutical Care. 2013;1(2):51-

4.

50. Akhzarmehr A, Fahimi F, Jamaati HR, Malekmohammad M, Najafi A, Bolursaz SM,

Masjedi MR, Hashemian SM. Comparison the efficacy of low-dose ciclesonide and

fluticasone propionate in mild to moderate persistent asthma. Pneumologia.(Accepted)

51. Fahimi F, Adimi P, Nadji SA, Naderi N*, Morowati S, Soleimani F, Masjedi MR. The

effect of polymorphisms of beta2 adrenoceptors on response to long acting beta2

agonists in Iranian asthmatic patients. Iranian Journal of Allergy, Asthma and

Immunology. 2013; 12(4): 383-390.

52. F. Fahimi*,. Tabarsi P*, Kobarfard F, DashtBozorg B, Goodarzi A, Dastan F,

Shahsavari N. Emami S, Habibi M, J. Salamzadeh J. Isoniazid, rifampicin and

pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary

tuberculosis. Int J Tuberc Lung Dis. 2013;17(12):1–5.

53. Talasaz AH, Khalili H*, Fahimi F, Jenab Y, Broumand MA, Salarifar M, Darabi F.

Effects of N-acteylcystein on the cardiac remodeling and major adverse events

following AMI; a randomized clinical trial. Am J Cardiovasc Drugs. 2013 Oct 9.

[Epub ahead of print]

54. Sharif-Kashani B, Hamraghani A, Salamzadeh J, Malekmohammad M, Behzadnia N,

Fahimi F*. The effect of Amlodipine and Sildenafil on the NT-ProBNP Level of

Patients with COPD –Induced Pulmonary Hypertension. Iranian J Pharm Res.

2014;supplement 13.

55. Khalilzadeh S, Hassanzad M, Baghaie N, Parsanejad N, Fahimi F*. Shwachman score

in clinical evaluation of cystic fibrosis. Journal of Comprehensive Pediatrics.

2013;3(2):82-85.

56. Bolandian Bafghi S, Rassouli M, Fahimi F, Salimi T, Alavi Majd H. Investigation the

relationship between the amount and type of medication errors with fatigue in nurses.

JAREC; 435-443.

57. Tabarsi P, Fahimi F*, , Heidarzadeh N, Haghgoo R , Kazempour M, Masjedi MR,

Velayati AA. The effect of Garcin® in preventing antiTB-induced hepatitis in newly

diagnosed tuberculosis patients. Iranian J Pharm Res. 2014;supplement 13.

Published Articles in Persian Journals:

هطار با بيوار در چرخ هراقبت از بيوارPatient consultation in pharmaceutical care cycle.

رازي. هجل. دكتر فاك فيويدكتر فرزا فرغي يا، 93 ظ 0931، دي 462ضوار

هعرفي بخص هراقبت اي داريي بيوارستاى دكتر هسيح داطري

Introduction to pharmaceutical care services of Masih Danesshvari hospital. دكتر هير غسايياى، دكتر اهيرابراين هيراليايي، دكتر ضادي بي اسذي، دكتر فاك

فيوي. هجل رازي. 013 ظ 0931، دي 462ضوار

ريييپرتاسيى الي -ارائ هذل تاهيي داراي كوياب براي بيواري اي ادرOrphan drugs procurement model for orphan diseases- pulmonary hypertension دكتر هحوذ رضا هسجذي، دكتر هجيذ هلك هحوذ، دكتر فاك فيوي، دكتر بابك ضريف.

رازي. هجل 22 ظ 0933، دي 454ضوار

باليسر در كدكاى DPIs pMDIsاستفاد از DPIs, PMDIs, Nebulizers in pediatric population. دكتر فاك فيوي، دكتر رداب حق گ. هجل رازي.

019 ظ 0933، آباى493ضوار

هقايس قذرت اثر استرييذاي هضعيComparison of topical steroids.

دكتر فاك فيوي؛ پريش افتخاري. هجل رازي. 09 ظ 0932، ارديبطت 032ضوار

هرري بر فارهاككيتيك داراي چطويReview of ophthalmic medication pharmacokinetics.

.رازي هجل .؛ دكتر الام حذيذي ؛ دكتر هحوذ رياضي اصفايدكتر فاك فيوي 29 ظ 0930، فررديي ها 023ضوار

TCAسويت

TCA toxicity. 0933، 03جلذ . هذااهجل .دكتر فاك فيوي

سخ در ضر تراى 5011ارزيابي

Evaluation of 5100 prescriptions in Tehran. 6-3ظ 0935، 00عسيس دلفاى. هجل بض. جلذ ؛بيژى جاگيري؛دكتر فاك فيوي

Submitted manuscripts

Masjedi MR, Fahimi F*, Sharif-Kashani B, Habibi M, Monjazebi F, Malekmohammad

M. Pulmonary arterial hypertension Prototype for National Protocol & Registry.

Iranian J Pharm Res. (Under review).

Baniasadi S, Kobarfard F, Fahimi F*. Stability assessment of isoniazid and rifampin

liquid dosage forms in a national referral center for tuberculosis. Indian Journal of

Pharmaceutical Sciences. (Under review).

Dastan F, Fahimi F*, Salamzadeh J, Tabarsi P, Kobarfard F, Goodarzi A, DashtBozorg

B. Prediction model of Drug-induced hepatitis in patients with pulmonary tuberculosis:

Evaluation of the incidence and risk factors. European Journal of Gastroenterology &

Hepatology. (Under review).

Dabiri Y, Fahimi f, Jamaati HR, Hashemian MR. The comparison of extemporaneously

preparation of omeprazole, pantoprazole oral suspension and intravenous pantoprazole

on the gastric pH of critically ill patients. Journal of Critical Care. (Under review).

Prepared manuscript for submission

Sefidani Forough A, Fahimi F*, Naderi N. Evaluation of the effect of text message in

renally impaired patients.

Fahimi F, Masoudi H, Shahsavari N, Kobarfard F*. The stability of extemporaneousely

prepared tacrolimus solution.

Fahimi F*, Sepideh Taghikhani. Medication errors in hospital: physicochemical and

order compatibility.

Pourdowlat G, Fahimi F*, Sadigh Mostofi S, Behzadnia N, Malekmohammad M,

Masjedi MR. Is there a new indication and route of administration for an old drug in

pulmonary hypertension (PH) secondary to COPD? A pilot evaluation.

Published Books:

1. Applied tables for physicians and pharmacists.

2. Questions and answers in asthma and COPD.

3. Questions and answers in tuberculosis, pneumonia, and swine flu.

4. What is warfarin? (booklet)

5. Quick guide for preparation and administration of IV drugs in ICU.

6. Educational handbook on the medication of organ transplanted patients.

7. Drug and therapeutic committee.

8. Medication cessation before surgery.

9. Comprehensive textbook of therapeutics.

10. Guideline for the pharmacotherapy of heart transplantation. (In press)

Selected Abstracts:

Fanak Fahimi, Bidjan Djahanguiri, Soha Namazi, and Aziz Delfan. Estimating the

Precentage of Generic and Parenteral Medications Dispensed as Well as Missing

Information on 5100 Prescriptions Filled at Community Pharmacies in Tehran.

International ASHP Congress, New Orleans, LA, USA. Dec., 2001.

Soha Namazi, Mojtaba Mojtahedzadeh, Fanak Fahimi, and Katayuon Kaviani.

Dosage Evaluation of Propranolol in Iranian Patients with Cardiovascular

Diseases. International ASHP Congress, New Orleans, LA, USA. Dec., 2001.

The correlation between Leptin & Fasting,The Congress of Health &

Ramadan,Tehran, Iran. Oct., 2001.

Leptin & obesity,,6th International Congress of Endocrine Disorders,Tehran, Iran.

Oct., 2001.

The influence of education in children with ADHD & affective D/O on

compliance their impovements,8th Iranian Seminar of Pharmaceutical Sciences,

Tehran, Iran. Aug., 27-29, 2002.

Which is a better alternative? Study of 404 prescriptions from pharmacoeconomic

point of view in Tehran”(lecture), 8th Iranian Seminar of Pharmaceutical

Sciences,Tehran, Iran. Aug., 27-29, 2002.

Metformin utilization review in Medical Center of Luisiana, 10th European

Association of Hospital Pharmacists (EAHP),Lisbon, Portugal. June., 2004.

A pilot study of commonly used drugs and its impact on economy: A cost

minimization analysis.10th European Association of Hospital Pharmacists

(EAHP). Lisbon, Portugal. March., 2005.

Comparative efficacy of glycerin suppositories in the elderly with functional

constipation. 35th European Symposium on Clinical Pharmacy (ESCP) Vienna,

Austria. Oct., 2006.

Transcription Errors Observed in a Teaching Hospital. 35th European Symposium

on Clinical Pharmacy (ESCP) Vienna, Austria. Oct., 2006.

An Observational study in accuracy of infusion pumps implications and related

admixture compatibility in an intensive care unit of a teaching hospital. 35th

European Symposium on Clinical Pharmacy (ESCP) Vienna, Austria. Oct., 2006.

Salamzadeh J, Fahimi F, Nematollahi M. Evaluation of the utilization patterns of

anti-asthma medications at a university hospital. ELECTRONIC POSTER

DISCUSSION, ERS Annual Congress, Stockholm, Sweden. Sep., 2007.

Fahimi F, Salamzadeh J, Jamaati HR, Fakharian A, Sohrabi S, Mohammadtaheri

Z. Does atorvastatin have effect on lung function and morbidity as add-on therapy

in asthmatic patients? ORAL PRESENTATION, ERS Annual Congress,

Stockholm, Sweden.Sep., 2007.

Baniasadi S, Fahimi F. Pattern of adverse drug reactions received by spontaneous

reporting in a respiratory teaching hospital The 3rd NRITLD-ERS Joint Congress

on Pulmonary Diseases, Intensive Care and Tuberculosis. Tehran. 2008.

Fahimi F, Baniasadi S, Kazemi B, Behzadnia N, Shafaghi B , Beizaee S,

Bandehpour M. A novel vitamin K epoxide reductase complex subunit-

1(VKORC1) mutation and the risk of bleeding. ERS Annual Congress, Berlin.

2008.

Amini S, Baniasadi S, Fahimi F. Adverse drug reactions in hospitalized patients

in the post coronary care unit ward of a teaching hospital. 11th Iranian

Pharmaceutical Siences Conference, Kerman. August., 18-21, 2008.

Fahimi F, Hoseinahmadi Z, Baniasadi S, Ghafari S. Cyclosporine blood levels in

heart transplant recipients. 11th Iranian Pharmaceutical Siences Conference,

Kerman. August., 18-21, 2008.

Baniasadi S, Fahimi F, Kobarfard F, Tabarsi P, Salamzadeh J, Hemmati S.

Isoniazid plasma cocentration monitoring in patients with pulmonary tuberculosis

at a teaching referral hospital. ERS Annual Congress, Vienna. 2009.

Baniasadi S, Eftekhari P, Tabarsi P, Raoufy MR, Masjedi MR,. Protective effect

of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. ERS Annual

Congress, Vienna. 2009.

Baniasadi S, Fahimi F, Salamzadeh J, Kobarfard F, Fakharian A, Abdollahi P,

Masjedi MR. Are spacers different in terms of lung bioavailability of salbutamol?

An observational comprative study. ERS Annual Congress, Vienna. 2009.

Fahimi F, Baniasadi S, Abrishami R, Hamidi F, Khodabakhshi N, Khayamikia M,

Eslami M. Cleanroom establishment and implementation for expensive IV drugs

in Masih Daneshvari Hospital. The 1st Iranian Clinical Pharmacy Congress, May.,

26-28, 2010.

Fahimi F, Abbasi Nazari M, Abrishami R, Sistanizad M, Soltani R, Mazidi T,

Faghihi T, Baniasadi S. Transcription errors observed in a teaching hospital. The

1st Iranian Clinical Pharmacy Congress, May., 26-28, 2010.

Baniasadi S, Fahimi F, Amini S, Khodadad K. Evaluation of the effect of

zingiber officinalis on nausea and vomiting in patients receiving cisplatin based

regimens. ERS Annual Congress, Barcelona. 2010.

Solaymani F, Fahimi F, Tavakoli M. Vancomycin utilization evaluation in a

teaching hospital between Feb. 2007 and May 2008 in Iran. International Society

for Pharmacoeconomics and Outcomes Research (ISPOR). Prague.Nov., 2010.

Baniasadi S, Fahimi F, Karimi M. Adverse drug reactions in a pulmonary

teaching hospital: Incidence, pattern, seriousness, and preventability. ERS Annual

Congress, Amsterdam. 2011.

Fahimi F, Sharif-Kashani B, Baniasadi S, Hamraghani A, Salamzadeh J.

Comparative effects of amlodipine and sildenafil on the NT-proBNP levels of

patients with COPD-induced pulmonary hypertension. ERS Annual Congress,

Amsterdam. 2011.

Fahimi F, Jamaati HR, Tabarsi P, Baniasadi S, Ghafari S, Hashemian SMR.

Clinical efficacy of bolus versus continuous-infusion of piperacillin-tazobactam in

VAP treatment. ERS Annual Congress, Amsterdam. 2011.

Baniasadi S, Fahimi F , Tabarsi P, Nadji SA, Khabiri S, Shahsavari N, Kobarfard

F. Therapeutic drug monitoring of isoniazid, rifampin, and pyrazinamide in HIV-

infected patients with tuberculosis. ERS Annual Congress, Vienna. 2012.

Baniasadi S, Dorudinia A , Mobarhan M, Fahimi F. Microbial contamination of

single- and multiple-dose vials after opening in apulmonary teaching hospital.

ERS Annual Congress, Vienna. 2012.

Professional Affiliation:

Iranian Medical Council Organization

National ADR monitoring Center Committee (Ministry of Health)

ADR NewsletterEvaluation Committee (Ministry of Health)

DTC & Formulary Committee (Masih Daneshvari Hospital)

Drug & Poison Information Center (Shahid Beheshti University of Medical Sciences)

Clinical Governance Committee (Masih Daneshvari Hospital)

Other Positions:

Head of the Pharmaceutical Care Department at Masih Daneshvari Hospital.

Member of Iranian Society of Clinical Pharmacy

Member of Clinical Pharmacy Board

Full Member of ACCP 2011

Research fields:

Clinical Trials (RCTs), Polymorphism, Pharmacovigilance (ADR, Medication Error),

Hospital Pharmacy (Management)

Diseases of interest: Thrombosis, Asthma, COPD, Pulmonary Hypertention, Pneumonia

References:

Available upon request.

http://www.sbmu.ac.ir/SiteDirectory/PharmacySchool/Pages/Facultymembers.aspx

https://www.google.com/search?q=%E2%80%A2+http%3A%2F%2Fwww.google.co

m%2Fsearch%3Fsourceid%3Dnavclient%26ie%3DUTF-

8%26rls%3DGGLR%2CGGLR%3A2006-

46%2CGGLR%3Aen%26q%3DFanak%2BFahimi&oq=%E2%80%A2+http%3A%2

F%2Fwww.google.com%2Fsearch%3Fsourceid%3Dnavclient%26ie%3DUTF-

8%26rls%3DGGLR%2CGGLR%3A2006-

46%2CGGLR%3Aen%26q%3DFanak%2BFahimi&aqs=chrome..69i57.513j0j9&sou

rceid=chrome&espv=210&es_sm=93&ie=UTF-

8#es_sm=93&espv=210&newwindow=1&q=fanak+fahimi

http://www.clinicalpharmacy.ir/default-88.aspx?memberId=835784